Clinical trial
A Study to Understand the Treatment Patterns in Patients With Chronic Bacterial Prostatitis (Category II), Chronic Pelvic Pain (Category IIIA, IIIB)Treataprost Added to Standard Antibiotic Treatment in Real-life Clinical Practice
NCT05306314 is registered in ClinicalTrials.gov with GMG Grand Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Understand the Treatment Patterns in Patients With Chronic Bacterial Prostatitis (Category II), Chronic Pelvic Pain (Category IIIA, IIIB)Treataprost Added to Standard Antibiotic Treatment in Real-life Clinical Practice
- Lead sponsor
- GMG Grand Medical
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 15, 2022
- Completion date
- October 15, 2023
- Enrollment
- 140 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
infection, bacterial, prostatitis, psa, quality of life